Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units
- PMID: 17944969
- DOI: 10.1111/j.1469-0691.2007.01835.x
Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units
Abstract
Severe nosocomial infections and multidrug resistance (MDR) are associated with a poor prognosis for patients in intensive care units. This is partly because most of these patients suffer from high disease severity and acute illness before the onset of infection. Nevertheless, the mortality attributed directly to infection can also be devastating. However, the attributable mortality can be limited by taking account of a number of key points. General infection prevention measures, prevention of cross-transmission and a policy of restricted antimicrobial use are all important because of their positive influence on the rates of infection and MDR. In turn, this will increase the odds for successful empirical coverage of the causative microorganism. Once infection occurs, benefits are to be expected from early recognition of the septic episode and prompt initiation of empirical antimicrobial therapy. The choice of empirical therapy should be based on the local bacterial ecology and patterns of resistance, the presence of risk-factors for MDR, and the colonisation status of the patient. Attention should also be given to adequate doses of antimicrobial agents and, if possible, elimination of the sources of infection, e.g., contaminated devices or intra-abdominal collections or leakages. In the latter case, timely surgical intervention is essential. In addition, haemodynamic stabilisation and optimisation of tissue oxygenation can save lives.
Similar articles
-
The intensive care unit in antimicrobial resistance.Postgrad Med. 2001 Feb;109(2 Suppl):60-9. doi: 10.3810/pgm.02.2001.suppl12.67. Postgrad Med. 2001. PMID: 19667559
-
Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist.Int J Antimicrob Agents. 2007 May;29(5):494-500. doi: 10.1016/j.ijantimicag.2006.10.017. Epub 2007 Mar 7. Int J Antimicrob Agents. 2007. PMID: 17346938 Review.
-
Antibiotic-resistant infections in the critically ill adult.Clin Lab Med. 2004 Jun;24(2):329-41. doi: 10.1016/j.cll.2004.03.002. Clin Lab Med. 2004. PMID: 15177843 Review.
-
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.J Antimicrob Chemother. 2008 Nov;62(5):1130-7. doi: 10.1093/jac/dkn289. Epub 2008 Jul 17. J Antimicrob Chemother. 2008. PMID: 18635519
-
Prevalent bacterial infections in intensive care units of Shiraz University of medical sciences teaching hospitals, Shiraz, Iran.Jpn J Infect Dis. 2009 Jul;62(4):249-53. Jpn J Infect Dis. 2009. PMID: 19628899
Cited by
-
Clinical efficacy and safety of linezolid in intensive care unit patients.J Intensive Med. 2022 Jul 5;3(1):65-72. doi: 10.1016/j.jointm.2022.05.006. eCollection 2023 Jan 31. J Intensive Med. 2022. PMID: 36789359 Free PMC article.
-
Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Patients in a Portuguese ICU.Cureus. 2022 Sep 26;14(9):e29610. doi: 10.7759/cureus.29610. eCollection 2022 Sep. Cureus. 2022. PMID: 36320987 Free PMC article.
-
Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.Intensive Crit Care Nurs. 2022 Jun;70:103227. doi: 10.1016/j.iccn.2022.103227. Epub 2022 Mar 3. Intensive Crit Care Nurs. 2022. PMID: 35249794 Free PMC article.
-
Targeting RNA with Next- and Third-Generation Sequencing Improves Pathogen Identification in Clinical Samples.Adv Sci (Weinh). 2021 Dec;8(23):e2102593. doi: 10.1002/advs.202102593. Epub 2021 Oct 23. Adv Sci (Weinh). 2021. PMID: 34687159 Free PMC article.
-
Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.Drugs. 2021 Jun;81(9):1065-1078. doi: 10.1007/s40265-021-01534-w. Epub 2021 May 26. Drugs. 2021. PMID: 34037963
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical